PL2051710T3 - Kompozycje i sposoby leczenia, zmniejszania, polepszania lub łagodzenia chorób tylnego odcinka oka - Google Patents
Kompozycje i sposoby leczenia, zmniejszania, polepszania lub łagodzenia chorób tylnego odcinka okaInfo
- Publication number
- PL2051710T3 PL2051710T3 PL07813637T PL07813637T PL2051710T3 PL 2051710 T3 PL2051710 T3 PL 2051710T3 PL 07813637 T PL07813637 T PL 07813637T PL 07813637 T PL07813637 T PL 07813637T PL 2051710 T3 PL2051710 T3 PL 2051710T3
- Authority
- PL
- Poland
- Prior art keywords
- ameliorating
- compositions
- treating
- reducing
- methods
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- JFUAWXPBHXKZGA-IBGZPJMESA-N 4-fluoro-2-[(4r)-5,5,5-trifluoro-4-hydroxy-2-methyl-4-(1h-pyrrolo[2,3-c]pyridin-2-ylmethyl)pentan-2-yl]phenol Chemical compound C([C@@](O)(CC=1NC2=CN=CC=C2C=1)C(F)(F)F)C(C)(C)C1=CC(F)=CC=C1O JFUAWXPBHXKZGA-IBGZPJMESA-N 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 239000004037 angiogenesis inhibitor Substances 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 229940124750 glucocorticoid receptor agonist Drugs 0.000 abstract 1
- 238000002513 implantation Methods 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83607806P | 2006-08-07 | 2006-08-07 | |
| PCT/US2007/074943 WO2008021729A2 (en) | 2006-08-07 | 2007-08-01 | Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases |
| EP07813637A EP2051710B1 (en) | 2006-08-07 | 2007-08-01 | Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2051710T3 true PL2051710T3 (pl) | 2012-03-30 |
Family
ID=38823645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07813637T PL2051710T3 (pl) | 2006-08-07 | 2007-08-01 | Kompozycje i sposoby leczenia, zmniejszania, polepszania lub łagodzenia chorób tylnego odcinka oka |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20080031884A1 (pl) |
| EP (1) | EP2051710B1 (pl) |
| JP (1) | JP2010500364A (pl) |
| KR (1) | KR20090051076A (pl) |
| CN (1) | CN101522187A (pl) |
| AT (1) | ATE531366T1 (pl) |
| AU (1) | AU2007284176B2 (pl) |
| BR (1) | BRPI0714817A2 (pl) |
| CA (1) | CA2660167C (pl) |
| CY (1) | CY1112269T1 (pl) |
| DK (1) | DK2051710T3 (pl) |
| ES (1) | ES2373999T3 (pl) |
| MX (1) | MX2009001333A (pl) |
| PL (1) | PL2051710T3 (pl) |
| PT (1) | PT2051710E (pl) |
| SI (1) | SI2051710T1 (pl) |
| TW (1) | TWI378928B (pl) |
| WO (1) | WO2008021729A2 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2397140A1 (en) * | 2006-08-31 | 2011-12-21 | Bausch & Lomb Incorporated | Compositions and methods for treating or preventing glaucoma or progression thereof |
| US20090042936A1 (en) * | 2007-08-10 | 2009-02-12 | Ward Keith W | Compositions and Methods for Treating or Controlling Anterior-Segment Inflammation |
| JP2011502990A (ja) * | 2007-11-05 | 2011-01-27 | ボーシュ アンド ローム インコーポレイティド | 薬物送達用ビヒクルとしての水非混和性物質 |
| US20090239836A1 (en) * | 2008-03-24 | 2009-09-24 | Mary Lee Ciolkowski | Multifunctional Ophthalmic Compositions |
| US20100008993A1 (en) * | 2008-07-14 | 2010-01-14 | Proksch Joel W | Compositions and Methods for Increasing Bioavailability of Topical Ophthalmic Drugs |
| US20110077270A1 (en) * | 2009-04-21 | 2011-03-31 | Pfeffer Bruce A | Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure |
| US20110189174A1 (en) * | 2010-02-01 | 2011-08-04 | Afshin Shafiee | Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization |
| RU2559585C2 (ru) * | 2013-12-26 | 2015-08-10 | Федеральное бюджетное учреждение науки "Уфимский научно-исследовательский институт медицины труда и экологии человека" | Способ диагностики раннего воздействия вредных производственных факторов на организм работников, занятых в производстве синтетических смол не более 5 лет |
| CA3123490A1 (en) | 2019-01-22 | 2020-07-30 | Akribes Biomedical Gmbh | Selective glucocorticoid receptor modifiers for treating impaired skin wound healing |
| WO2021163610A1 (en) * | 2020-02-13 | 2021-08-19 | Spiral Therapeutics Inc. | Treatment of otic diseases and conditions |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4580559A (en) * | 1984-07-24 | 1986-04-08 | Esperance Francis A L | Indirect ophthalmoscopic photocoagulation delivery system for retinal surgery |
| WO2000000194A1 (en) * | 1998-06-27 | 2000-01-06 | Photogenesis, Inc. | Ophthalmic uses of ppargamma agonists and ppargamma antagonists |
| US20040121014A1 (en) * | 1999-03-22 | 2004-06-24 | Control Delivery Systems, Inc. | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| JP4503436B2 (ja) * | 2002-07-08 | 2010-07-14 | ファイザー・プロダクツ・インク | 糖質コルチコイド受容体のモジュレーター |
| US7235662B2 (en) * | 2003-06-11 | 2007-06-26 | Bristol-Myers Squibb Company | Modulators of the glucocorticoid receptor and method |
| US8685435B2 (en) * | 2004-04-30 | 2014-04-01 | Allergan, Inc. | Extended release biodegradable ocular implants |
| DE102004055633A1 (de) * | 2004-11-12 | 2006-05-18 | Schering Ag | 5-substituierte Chinolin- und Isochinolin-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer |
-
2007
- 2007-08-01 AT AT07813637T patent/ATE531366T1/de active
- 2007-08-01 BR BRPI0714817-8A patent/BRPI0714817A2/pt not_active IP Right Cessation
- 2007-08-01 SI SI200730833T patent/SI2051710T1/sl unknown
- 2007-08-01 AU AU2007284176A patent/AU2007284176B2/en not_active Ceased
- 2007-08-01 DK DK07813637.1T patent/DK2051710T3/da active
- 2007-08-01 ES ES07813637T patent/ES2373999T3/es active Active
- 2007-08-01 US US11/832,294 patent/US20080031884A1/en not_active Abandoned
- 2007-08-01 JP JP2009523901A patent/JP2010500364A/ja active Pending
- 2007-08-01 KR KR1020097004766A patent/KR20090051076A/ko not_active Ceased
- 2007-08-01 CN CNA2007800366463A patent/CN101522187A/zh active Pending
- 2007-08-01 EP EP07813637A patent/EP2051710B1/en not_active Not-in-force
- 2007-08-01 PT PT07813637T patent/PT2051710E/pt unknown
- 2007-08-01 CA CA2660167A patent/CA2660167C/en not_active Expired - Fee Related
- 2007-08-01 WO PCT/US2007/074943 patent/WO2008021729A2/en not_active Ceased
- 2007-08-01 PL PL07813637T patent/PL2051710T3/pl unknown
- 2007-08-01 MX MX2009001333A patent/MX2009001333A/es active IP Right Grant
- 2007-08-06 TW TW096128874A patent/TWI378928B/zh not_active IP Right Cessation
-
2012
- 2012-02-01 CY CY20121100109T patent/CY1112269T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008021729A3 (en) | 2008-10-09 |
| CA2660167C (en) | 2012-04-10 |
| TW200815416A (en) | 2008-04-01 |
| AU2007284176B2 (en) | 2013-03-28 |
| WO2008021729A2 (en) | 2008-02-21 |
| BRPI0714817A2 (pt) | 2013-05-21 |
| CY1112269T1 (el) | 2015-12-09 |
| JP2010500364A (ja) | 2010-01-07 |
| HK1127556A1 (en) | 2009-10-02 |
| SI2051710T1 (sl) | 2012-02-29 |
| CA2660167A1 (en) | 2008-02-21 |
| KR20090051076A (ko) | 2009-05-20 |
| EP2051710B1 (en) | 2011-11-02 |
| ES2373999T3 (es) | 2012-02-10 |
| EP2051710A2 (en) | 2009-04-29 |
| AU2007284176A1 (en) | 2008-02-21 |
| ATE531366T1 (de) | 2011-11-15 |
| PT2051710E (pt) | 2012-02-08 |
| CN101522187A (zh) | 2009-09-02 |
| DK2051710T3 (da) | 2012-02-20 |
| MX2009001333A (es) | 2009-02-13 |
| TWI378928B (en) | 2012-12-11 |
| US20080031884A1 (en) | 2008-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2051710T3 (pl) | Kompozycje i sposoby leczenia, zmniejszania, polepszania lub łagodzenia chorób tylnego odcinka oka | |
| AR049955A1 (es) | Composiciones y metodos para el tratamiento de trastornos metabolicos | |
| WO2003068171A3 (en) | Method and composition for treatment of inflammation and aids-associated neurological disorders | |
| MX2009009624A (es) | Droxidopa y composicion farmaceutica de la misma para el tratamiento de la fibromialgia. | |
| MXPA02007117A (es) | Composiciones para suministrar un antagonista de cortisol.. | |
| WO2007143607A3 (en) | Method of treating atrophic vaginitis | |
| TNSN07209A1 (en) | Dosage regimen of an s1p receptor agonist | |
| WO2004089415A3 (en) | COMBINATIONS OF AN 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITOR AND A GLUCOCORTICOID RECEPTOR AGONIST | |
| BR0308290A (pt) | Tratamento e prevenção de distúrbios inflamatórios | |
| ATE549022T1 (de) | Behandlung von infektionen und deren folgeleiden mit kombinierten dissoziierten glocucorticoid- rezeptor-agonisten und antiinfektionswirkstoffen | |
| MX2010005210A (es) | Formulacion de aceite de oliva para alivio del dolor. | |
| WO2001030802A3 (en) | Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies | |
| WO2008112773A3 (en) | Droxidopa and pharmaceutical composition thereof for the treatment of neurally mediated hypotension | |
| WO2008005686A8 (en) | Compositions comprising a dissociated glucocorticoid receptor agonist and an immunosuppressive agent for treating dry eye | |
| UA90668C2 (ru) | Состав для лечения хронической венозной недостаточности, который содержит водный экстракт листьев красного винограда и противовоспалительное средство | |
| WO2007062093A3 (en) | Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor | |
| MX2013014518A (es) | Composiciones y metodos para tratar, controlar, reducir, o mejorar el dolor inflamatorio. | |
| WO2005074536A3 (en) | Compositions and methods using proton pump inhibitors | |
| PT2061444E (pt) | Composições e métodos de tratamento, controlo, redução, melhoramento ou prevenção de alergias | |
| MX2010001370A (es) | Composiciones que comprenden agonista del receptor glucocorticoide disociado para tratar o controlar inflamacion del segmento anterior. | |
| WO2008027796A3 (en) | Compositions and methods for treating or preventing glaucoma or progression thereof | |
| MY161853A (en) | Pharmaceutical composition and method for treating hypertension | |
| WO2006002096A3 (en) | Low doses of l-citrulline for treating diseases | |
| WO2005123192A3 (en) | Improving pain treatment with strontium combinations | |
| CA2866819C (en) | Method for treating inflammation |